✦ LIBER ✦

Combined cytotoxic and endocrine therapy in postmenopausal patients with advanced breast cancer. A randomized study of CMF vs CMF plus tamoxifen

✍ Scribed by Mouridsen, H.T; Rose, C; Engelsman, E; Sylvester, R; Rotmensz, N

Book ID: 122402398
Publisher: Elsevier Science
Year: 1985
Weight: 954 KB
Volume: 21
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(85)90128-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined cytotoxic and endocrine therapy

Combined cytotoxic and endocrine therapy in postmenopausal patients with advanced breast cancer: A randomized eortc study of CMF vs CMF + tamoxifen

✍ H.T. Mouridsen; C. Rose; E. Engelsmann; R. Sylvester; N. Rotmensz 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 581 KB

Tamoxifen plus sequential CMF chemothera

Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer: A randomized trial

✍ John H. Glick; Richard H. Creech; Susan Torri; Christopher Holroyde; Harvey Brod 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 631 KB

Randomized clinical trial of tamoxifen p

Randomized clinical trial of tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal women with advanced breast cancer

✍ John H. Glick; Richard H. Creech; Susan Torri; Christopher Holroyde; Harvey Brod 📂 Article 📅 1981 🏛 Springer US 🌐 English ⚖ 914 KB

Endocrine consequences of CMF adjuvant t

Endocrine consequences of CMF adjuvant therapy in premenopausal and postmenopausal breast cancer patients

✍ Ann M. Dnistrian; Morton K. Schwartz; Alfred A. Fracchia; Richard J. Kaufman; Th 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 3 views

CMF and mitoxantrone in elderly patients

CMF and mitoxantrone in elderly patients with advanced breast cancer. A randomized phase II study

✍ M.A. Nooij; E. Steenland; L.V.A.M. Beex; B. van de Bos; L. Ruiter; J.C.J.M. Haes 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Treatment of metastatic breast cancer in

Treatment of metastatic breast cancer in estrogen receptor positive patients a randomized trial comparing tamoxifen alone versus tamoxifen plus CMF

✍ W. R. Bezwoda; D. Derman; N. G. De Moor; M. Lange; J. Levin 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB 👁 2 views